[F-18]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy
(2015) In Scandinavian Journal of Urology 49(4). p.296-301- Abstract
- Objective. The aim of this study was to evaluate the clinical use of [F-18]-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in addition to conventional preoperative radiological investigations in a defined group of patients with high-risk muscle-invasive bladder cancer. Materials and methods. In total, 103 patients with high-risk muscle-invasive bladder cancer defined as stage T3/T4 disease or as stage T2 with hydronephrosis or high-risk histological features, who were provisionally scheduled to undergo cystectomy, were prospectively recruited to the study. The patients were referred to FDG-PET/CT in addition to standard preoperative investigation with computed tomography (CT). The final treatment decision... (More)
- Objective. The aim of this study was to evaluate the clinical use of [F-18]-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in addition to conventional preoperative radiological investigations in a defined group of patients with high-risk muscle-invasive bladder cancer. Materials and methods. In total, 103 patients with high-risk muscle-invasive bladder cancer defined as stage T3/T4 disease or as stage T2 with hydronephrosis or high-risk histological features, who were provisionally scheduled to undergo cystectomy, were prospectively recruited to the study. The patients were referred to FDG-PET/CT in addition to standard preoperative investigation with computed tomography (CT). The final treatment decision was reached at a multidisciplinary conference based on all available information including the FDG-PET/Cf findings. Results. Compared to CT alone, FDG-PET/CT provided more supplemental findings suggesting malignant manifestations in 48 (47%) of the 103 patients. The additional FDG-PET/CT findings led to an altered provisional treatment plan in 28 out of 103 patients (27%), detection of disseminated bladder cancer and subsequent cancellation of the initially intended cystectomy in 16 patients, and identification of disseminated disease and treatment with induction chemotherapy before radical cystectomy in 12 patients. Conclusions. Preoperative FDG-PET/CT changed the treatment plan for a considerable proportion (27%) of the present patients. Accordingly, such examination can potentially improve the preoperative staging of cystectomy patients with high-risk features, and may also reduce the number of futile operations in patients with advanced disease who are beyond cure. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/7979246
- author
- Kollberg, Petter LU ; Almquist, Helén LU ; Bläckberg, Mats LU ; Cronberg, Carin LU ; Garpered, Sabine LU ; Gudjonsson, Sigurdur LU ; Kleist, Jakob ; Lyttkens, Kerstin LU ; Hultman Patschan, Oliver LU and Liedberg, Fredrik LU
- organization
-
- Clinical Physiology (Lund)
- Clinical Sciences, Helsingborg
- Radiology Diagnostics, Malmö (research group)
- Clinical Physiology and Nuclear Medicine, Malmö (research group)
- Urology (research group)
- Diagnostic Radiology, (Lund)
- Urological research, Malmö (research group)
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Bladder cancer, computed tomography, positron emission tomography, radical cystectomy
- in
- Scandinavian Journal of Urology
- volume
- 49
- issue
- 4
- pages
- 296 - 301
- publisher
- Taylor & Francis
- external identifiers
-
- wos:000359170200005
- scopus:84937569964
- pmid:25623843
- ISSN
- 2168-1813
- DOI
- 10.3109/21681805.2014.990053
- language
- English
- LU publication?
- yes
- id
- bc48d216-320d-4090-b600-a8b87ab89dcc (old id 7979246)
- date added to LUP
- 2016-04-01 10:29:52
- date last changed
- 2023-08-31 04:27:57
@article{bc48d216-320d-4090-b600-a8b87ab89dcc, abstract = {{Objective. The aim of this study was to evaluate the clinical use of [F-18]-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in addition to conventional preoperative radiological investigations in a defined group of patients with high-risk muscle-invasive bladder cancer. Materials and methods. In total, 103 patients with high-risk muscle-invasive bladder cancer defined as stage T3/T4 disease or as stage T2 with hydronephrosis or high-risk histological features, who were provisionally scheduled to undergo cystectomy, were prospectively recruited to the study. The patients were referred to FDG-PET/CT in addition to standard preoperative investigation with computed tomography (CT). The final treatment decision was reached at a multidisciplinary conference based on all available information including the FDG-PET/Cf findings. Results. Compared to CT alone, FDG-PET/CT provided more supplemental findings suggesting malignant manifestations in 48 (47%) of the 103 patients. The additional FDG-PET/CT findings led to an altered provisional treatment plan in 28 out of 103 patients (27%), detection of disseminated bladder cancer and subsequent cancellation of the initially intended cystectomy in 16 patients, and identification of disseminated disease and treatment with induction chemotherapy before radical cystectomy in 12 patients. Conclusions. Preoperative FDG-PET/CT changed the treatment plan for a considerable proportion (27%) of the present patients. Accordingly, such examination can potentially improve the preoperative staging of cystectomy patients with high-risk features, and may also reduce the number of futile operations in patients with advanced disease who are beyond cure.}}, author = {{Kollberg, Petter and Almquist, Helén and Bläckberg, Mats and Cronberg, Carin and Garpered, Sabine and Gudjonsson, Sigurdur and Kleist, Jakob and Lyttkens, Kerstin and Hultman Patschan, Oliver and Liedberg, Fredrik}}, issn = {{2168-1813}}, keywords = {{Bladder cancer; computed tomography; positron emission tomography; radical cystectomy}}, language = {{eng}}, number = {{4}}, pages = {{296--301}}, publisher = {{Taylor & Francis}}, series = {{Scandinavian Journal of Urology}}, title = {{[F-18]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy}}, url = {{http://dx.doi.org/10.3109/21681805.2014.990053}}, doi = {{10.3109/21681805.2014.990053}}, volume = {{49}}, year = {{2015}}, }